(Total Views: 65)
Posted On: 08/22/2025 8:56:39 AM
Post# of 25710
$VRHI Open Market Transactions (CEO & Director) - VRHI
https://www.otcmarkets.com/stock/VRHI/news/Op...?id=490128
VERI MEDTECH (VRHI) Announces CEO & Director Purchase: 7,953 Additional Shares of VRHI Stock in Open Market Transactions
NEW YORK, August 22, 2025 - OTC Markets -- Veri Medtech Holdings, Inc. (Stock Ticker Symbol: “VRHI”) ("Veri Medtech"
, healthcare technology platform, announced today that via open market transactions: (1) Sam Adetunji, CEO, completed the purchase of an additional 6,000 shares of VRHI stock at an average price per share of $0.98; and (2) Danny Wilson, Director, completed the purchase of an additional 1,953 shares of VRHI stock at an average price per share of $0.9387 per share, for a combined total of: 7,953 shares. With these purchases, Mr. Adetunji beneficially owns 7,643,385 shares and Mr. Wilson beneficially owns: 491,876 shares of VRHI stock.
Q2 Key Accomplishments:
$2.86 Million in Revenue
Initiated Audit Process with PCAOB Auditor (in preparation for uplisting)
Relaunched www.VeriMedTech.com
Engaged in Discussions for Accretive Opportunities in Mergers/Acquisitions (Healthcare Technology Companies)
https://www.otcmarkets.com/stock/VRHI/news/Op...?id=490128
VERI MEDTECH (VRHI) Announces CEO & Director Purchase: 7,953 Additional Shares of VRHI Stock in Open Market Transactions
NEW YORK, August 22, 2025 - OTC Markets -- Veri Medtech Holdings, Inc. (Stock Ticker Symbol: “VRHI”) ("Veri Medtech"
, healthcare technology platform, announced today that via open market transactions: (1) Sam Adetunji, CEO, completed the purchase of an additional 6,000 shares of VRHI stock at an average price per share of $0.98; and (2) Danny Wilson, Director, completed the purchase of an additional 1,953 shares of VRHI stock at an average price per share of $0.9387 per share, for a combined total of: 7,953 shares. With these purchases, Mr. Adetunji beneficially owns 7,643,385 shares and Mr. Wilson beneficially owns: 491,876 shares of VRHI stock. Q2 Key Accomplishments:
$2.86 Million in Revenue
Initiated Audit Process with PCAOB Auditor (in preparation for uplisting)
Relaunched www.VeriMedTech.com
Engaged in Discussions for Accretive Opportunities in Mergers/Acquisitions (Healthcare Technology Companies)
(0)
(0)
